DTC

Belviq scripts jump on DTC, rep push

Belviq scripts jump on DTC, rep push

By

Arena's recent quarter shows weight-loss drug Belviq is on the rise. It follows a DTC push and the recent addition of reps by co-marketer Eisai.

FDA examines DTC close up

FDA examines DTC close up

By

The regulator's latest study will use eye-tracking tools.

Bayer encourages daily calcium with a side of defiance

Its "Beauty is Bone Deep" campaign looks at beauty from the inside.

The year's most popular stories

The year's most popular stories

Our year-end list captures the 10 that sparked heaviest interest.

Osbourne joins Teva for "You Don't Know Jack About MS"

Osbourne joins Teva for "You Don't Know Jack About MS"

By

Famous from his reality show, "The Osbournes," Jack narrates his life with MS in a web documentary series.

FDA slams 23andMe over genetic testing device

FDA slams 23andMe over genetic testing device

By

Regulators say the company has not received approval for the device's touted functions.

Dendreon reorganizes, tries to keep sales reps

Dendreon reorganizes, tries to keep sales reps

By

The company says it will cut staff and costs, focus on big accounts and try to keep sales reps from leaving.

FDA peers into teenage brain

The regulator will study how teens perceive ads and if targeted media needs unique standards.

Report: Dendreon looking for buyer

The prostate cancer drug company is reportedly seeking a buyer to turn things around.

Analyst: Eisai should hire more Belviq reps

Analyst: Eisai should hire more Belviq reps

By

A Credit Suisse analyst notes that the company will need to make a significant impact to meet even lowered expectations. A possible fix: more sales reps behind Belviq.

Genetic testing firm airs TV spot as part of $5M ad buy

Genetic testing firm airs TV spot as part of $5M ad buy

By

23andMe aired its first TV ad Monday, in a bid to build the audience for DNA sequencing.

I'll take DTC for $10 million, Alex

I'll take DTC for $10 million, Alex

The Wizards of White Oak are spending $10 million on DTC ad research. Is this a wise use of sparse agency resources?

Purdue puts Intermezzo DTC to bed

Purdue puts Intermezzo DTC to bed

By

Marketing partner Transcept pulled 90 sales reps and Purdue closed out the majority of its DTC outreach in March.

Pharmas are cool with YouTube but fear Twitter

Pharmas are cool with YouTube but fear Twitter

By

Among social media channels, healthcare execs are most comfortable with YouTube and least comfortable with Twitter, a survey suggests.

FDA gut-checks DTC clarity

By

The new survey will study whether patients understand how efficacy is calculated and experiment with ways to make communications clearer.

Docs haven't mellowed on DTC, snap poll suggests

Docs haven't mellowed on DTC, snap poll suggests

By

The FDA wants to know how physician attitudes towards direct-to-consumer advertising have evolved since the agency last asked them, in 2002. If a snap poll by CMI/Compas is any indication, drug companies probably won't like the answers.

Fabry film spotlights a rare disease

Fabry film spotlights a rare disease

By

Genzyme is taking rare disease awareness to another level with a documentary film, dubbed "Facing Fabry Together," that follows four families grappling with the genetic disorder.

Higher prices keep Lilly's quarter flat; Cymbalta DTC pull-back planned

By

Lilly said sales-force downsizing was the right move considering the current portfolio mix and generics shadow. Management also teased some vague pipeline details.

FDA widens scope of DTC impact survey

By

The agency is revisiting the impact DTC advertising can have on healthcare. What's new: NPs and PAs are being asked for input.

OPDP takes an integrated approach to ad reviews

By

FDA's Office of Prescription Drug Promotion is taking an integrated approach to reviewing promotional materials and shedding its consumer- and professional-directed silos.

Business briefs: Pharma's ad spend, Baby sheds HIV status

Pharma pared back its ad spend in 2012, a baby born HIV-positive is virus-free two-and-a-half years later, and Boston Children's Hospital is making its own apps.

Razzed for lax DTC self-policing, PhRMA accentuates the positive

Razzed for lax DTC self-policing, PhRMA accentuates the positive

By

PhRMA issued a terse response to a study claiming that ED drug advertisers more or less ignored the trade group's Guiding Principles for Direct to Consumer ads, a self-policing regime implemented in 2005 to fend off talk of a ban on drug ads.

Meta-survey suggests favorable risk/benefit profile for DTC ads

Meta-survey suggests favorable risk/benefit profile for DTC ads

By

A comprehensive survey of the scientific literature on direct-to-consumer advertising of prescription drugs reads more like the industry's case for DTC than you might expect—with a few big caveats.

Blood cancer charity in branding blitz

Blood cancer charity in branding blitz

By

The Leukemia & Lymphoma Society is looking to raise its profile—and donations—with its first-ever large-scale ad campaign.

Purdue takes to the airwaves with Intermezzo ads

Purdue takes to the airwaves with Intermezzo ads

By

After several years of quiet among prescription sleep aids, Purdue Pharma has issued a wake up call to the category with an ad campaign featuring an adorably memorable anthropomorphic lightbulb.

Merck finds "dual modality" in DTC helps viewers grasp risks

By

A Merck study bolsters FDA's case for requiring that TV ads for prescription drugs present risks in text as well as the voiceover.

Transcept, Purdue plan DTC effort to revive sleep-drug launch

By

Facing lower-than-expected demand, Purdue and Transcept are broadening the commercial strategy for Intermezzo to include DTC and a larger selling force.

Sanofi snags Elizabeth Perkins for Lantus campaign

Sanofi snags Elizabeth Perkins for Lantus campaign

By

Sanofi has recruited actress Elizabeth Perkins, who has type 1 diabetes, to serve as the face of its Diabetes Co-Stars awareness campaign.

Amgen's Prolia, Enbrel get sales overhauls, DTC

Amgen's Prolia, Enbrel get sales overhauls, DTC

Sales of Amgen's Prolia are set to rise after a "soft" quarter, thanks to a sales force overhaul and an impending return to TV advertising, the company said in a third quarter results call.

Sanofi launches Fluzone DTC with prickly-cute creative

Sanofi launches Fluzone DTC with prickly-cute creative

By

Sanofi Pasteur has launched its first consumer advertising for Fluzone Intradermal, featuring a prickly pitch-critter meant to stress the flu vaccine's extra-thin needle.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters